The significance of determination of insulin-like growth factor-1、insulin-like growth factor binding protein-3 in glioma patients

LU Junsong,LI Xiangdong,ZHU Fengqing,YANG Yilin,XIA Xiwei,ZHU Weiwei
2013-01-01
Abstract:Objective: To determine expression of insulin-like growth factor-1(IGF-1) in tumor tissues and serum IGF-1、insulin-like growth factor binding protein-3(IGFBP-3) levels in glioma patients,and to investigate both relationships.Meanwhile to discuss the exact roles of IGF-1,IGFBP-3 in the development of glioma.So with the theory,we can detect early glioma by detecting serum IGF-1,IGFBP-3 levels.Methods: The experiment was divided into two groups:healthy control group(healthy volunteer) and glioma group,each group including 30 cases.A 4 mL blood sample from each fasting case was drawn in the early morning,and which was separated by centrifugation immediately and was stored under-20 ℃.Serum IGF-1 and IGFBP-3 levels were determined by immunoradiometric assays(IRMA).To take tissue samples in the operation,and which were made in routine HE staining and IGF-1 immunohistochemical staining.Staining results were observed with microscope.Data were analyzed by χ2 test,and the significance level was P<0.05.Results:(1)Serum IGF-1 levels in glioma were significantly higher than those in healthy control cases(P<0.01),and increased serum IGF-1 levels correlated with glioma's malignancy.(2) Serum IGFBP-3 levels in glioma were significantly higher than those in healthy control cases(P<0.01).(3)Serum IGF-1 levels correlated significantly with serum IGFBP-3 levels in two groups(r=0.594,0.474,0.375,P<0.05).(4)Less expressions of IGF-1 were detected in normal brain tissues,but expressions of IGF-1 in glioma were obviously increased(P<0.05).Conclusions: IGF-1 and IGFBP-3 might promote the development of glioma.There was meaningful clinical value in determination's serum IGF-1 and IGFBP-3 levels serving as early indicators of glioma.
What problem does this paper attempt to address?